High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.1M
$1,149,054
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
MAZE
M
Maze Therapeutics, Inc.
Sohn Catherine A.
• Director
Equity Compensation
2026-01-07
$280,506x6
|
||||||
| MAZE |
Maze Therapeutics, Inc.
|
Director
Equity Compensation
|
2026-01-07 | $280,506x6 | M | Form 4 |
|
MAZE
S
Maze Therapeutics, Inc.
Sohn Catherine A.
• Director
Discretionary Sell
2026-01-07
$1,052,785Large
|
||||||
| MAZE |
Maze Therapeutics, Inc.
|
Director
Discretionary Sell
|
2026-01-07 | $1,052,785Large | S | Form 4 |
|
MAZE
M
Maze Therapeutics, Inc.
Sohn Catherine A.
• Director
Equity Compensation
2026-01-06
$25,977x2
|
||||||
| MAZE |
Maze Therapeutics, Inc.
|
Director
Equity Compensation
|
2026-01-06 | $25,977x2 | M | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
Director
Discretionary Sell
|
2026-01-06 | $96,270 | S | Form 4 |